{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:35:32Z","timestamp":1781508932837,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"vor","delay-in-days":706,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ligue Contre le Cancer (comit\u00e9 du Doubs, CCIR-GE)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JEGH"],"DOI":"10.1016\/j.jegh.2013.11.003","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T06:15:42Z","timestamp":1390544142000},"page":"35","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence and risk factors of human papillomavirus infection types 16\/18\/45 in a cohort of French females aged 15\u201323 years"],"prefix":"10.1007","volume":"4","author":[{"given":"Ariane","family":"Baudu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Pr\u00e9tet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Riethmuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Chotard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Mougin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Mercier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014]]},"reference":[{"key":"10.1016\/j.jegh.2013.11.003_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: human papillomavirus and cervical cancer\u2013burden and assessment of causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jegh.2013.11.003_b0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jadohealth.2005.09.011","article-title":"Impact of HPV infection in adolescent populations","volume":"37","author":"Moscicki","year":"2005","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jegh.2013.11.003_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.jegh.2013.11.003_b0025","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jegh.2013.11.003_b0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jegh.2013.11.003_b0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer","volume":"180","author":"Franco","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jegh.2013.11.003_b0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-1702(02)00188-0","article-title":"Environmental co-factors in HPV carcinogenesis","volume":"89","author":"Castellsague","year":"2002","journal-title":"Virus Res"},{"key":"10.1016\/j.jegh.2013.11.003_b0045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(05)70273-4","article-title":"Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jegh.2013.11.003_b0050","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jegh.2013.11.003_b0055","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","article-title":"Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study","volume":"359","author":"Munoz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jegh.2013.11.003_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.jncimonographs.a003478","article-title":"Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients\u2013assessing their roles as human papillomavirus cofactors","volume":"31","author":"Castle","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jegh.2013.11.003_b0065","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1016\/j.vaccine.2012.04.006","article-title":"Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation","volume":"30","author":"Howell-Jones","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jegh.2013.11.003_b0070","doi-asserted-by":"crossref","first-page":"e3743","DOI":"10.1371\/journal.pone.0003743","article-title":"Sexual behaviour and HPV infections in 18\u201329year old women in the pre-vaccine era in the Netherlands","volume":"3","author":"Lenselink","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jegh.2013.11.003_b0075","unstructured":"Europe WROf. Preparing for the introduction of HPV vaccine in the WHO European region: vaccine-preventable diseases and immunization programme, Copenhagen, 2008."},{"key":"10.1016\/j.jegh.2013.11.003_b0080","unstructured":"Afssaps. Mise sur le march\u00e9 du vaccin pour la pr\u00e9vention d\u2019infections li\u00e9es au virus papilloma, Paris, France, 2006."},{"key":"10.1016\/j.jegh.2013.11.003_b0085","unstructured":"Conseil sup\u00e9rieur d\u2019hygi\u00e8ne public. Avis du Comit\u00e9 technique des vaccinations et du Conseil sup\u00e9rieur d\u2019hygi\u00e8ne public de France relatif \u00e0 la vaccination contre les papillomavirus humains 6, 11, 16 et 18. Paris, France, 2007."},{"key":"10.1016\/j.jegh.2013.11.003_b0090","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ijc.23093","article-title":"Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2\/3) in France: EDITH study","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jegh.2013.11.003_b0095","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1016\/j.vaccine.2012.06.013","article-title":"Prevalence of type-specific human papillomavirus infection among women in France: implications for screening, vaccination, and a future generation of multivalent HPV vaccines","volume":"30","author":"Monsonego","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jegh.2013.11.003_b0100","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","article-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark","volume":"123","author":"Kjaer","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jegh.2013.11.003_b0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/00365548.2012.673231","article-title":"Pre-vaccination incidence of genital warts in 15\u201323-year-old women and men attending youth clinics in Stockholm, Sweden","volume":"44","author":"Wikstrom","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jegh.2013.11.003_b0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.vaccine.2012.10.087","article-title":"Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands","volume":"31","author":"Mollers","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jegh.2013.11.003_b0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2334-10-157","article-title":"Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18\u201324: results at recruitment","volume":"10","author":"Confortini","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jegh.2013.11.003_b0120","doi-asserted-by":"crossref","first-page":"A11","DOI":"10.1016\/j.vaccine.2008.10.095","article-title":"Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy)","volume":"27","author":"Masia","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jegh.2013.11.003_b0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jegh.2013.11.003_b0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gyobfe.2013.03.003","article-title":"Halfon P","volume":"41","author":"Monsonego","year":"2013","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jegh.2013.11.003_b0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-13-135","article-title":"Prevalence of high-risk HPV types and associated genital diseases in women born in 1988\/89 or 1983\/84-results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany","volume":"13","author":"Petry","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jegh.2013.11.003_b0140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.olq.0000204545.89516.0a","article-title":"Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy","volume":"33","author":"Manhart","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jegh.2013.11.003_b0145","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ejca.2004.01.021","article-title":"Detection of cervical precancer and cancer in a hospital population; benefits of testing for human papillomavirus","volume":"40","author":"Dalstein","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jegh.2013.11.003_b0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjc.6604162","article-title":"Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening","volume":"98","author":"Coupe","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jegh.2013.11.003_b0155","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2012.01.021","article-title":"Monitoring HPV type-specific prevalence over time through clinic-based surveillance: a perspective on vaccine effectiveness","volume":"30","author":"Gaffga","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jegh.2013.11.003_b0160","unstructured":"Bajos N BM. L\u2019enqu\u00eate \u00abContexte de la sexualit\u00e9 en France\u00bb. Ined\/Inserm 2006."},{"key":"10.1016\/j.jegh.2013.11.003_b0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ije\/dyn033","article-title":"Smoking and human papillomavirus infection: pooled analysis of the international agency for research on cancer HPV prevalence surveys","volume":"37","author":"Vaccarella","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jegh.2013.11.003_b0170","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jegh.2013.11.003_b0175","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1001\/jama.285.23.2995","article-title":"Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females","volume":"285","author":"Moscicki","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jegh.2013.11.003_b0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jegh.2013.11.003_b0185","first-page":"799","article-title":"Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?","volume":"6","author":"Kjaer","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jegh.2013.11.003_b0190","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-06-0129","article-title":"Human papillomavirus infections with multiple types and risk of cervical neoplasia","volume":"15","author":"Trottier","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 1","key":"10.1016\/j.jegh.2013.11.003_b0195","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"issue":"Suppl. 3","key":"10.1016\/j.jegh.2013.11.003_b0200","first-page":"S3\/42-51","article-title":"Chapter 5: updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jegh.2013.11.003_b0205","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00404-011-2155-8","article-title":"Prevalence and risk factors of HPV infection among women from various provinces of the world","volume":"285","author":"Vinodhini","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jegh.2013.11.003_b0210","doi-asserted-by":"crossref","first-page":"e27937","DOI":"10.1371\/journal.pone.0027937","article-title":"Human papillomavirus persistence in young unscreened women, a prospective cohort study","volume":"6","author":"Schmeink","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jegh.2013.11.003_b0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24\u201345years of age","volume":"105","author":"Castellsague","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jegh.2013.11.003_b0220","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jegh.2013.11.003_b0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mbs.2011.02.009","article-title":"The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study","volume":"231","author":"Brown","year":"2011","journal-title":"Math Biosci"},{"key":"10.1016\/j.jegh.2013.11.003_b0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jegh.2013.11.003_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.04.08022-en","article-title":"European centre for disease prevention and control issues guidance for the introduction of human papillomavirus (HPV) vaccines in European Union countries","volume":"13","author":"Hamers","year":"2008","journal-title":"Euro Surveill"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210600613001251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210600613001251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:14:42Z","timestamp":1739477682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.jegh.2013.11.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014]]}},"alternative-id":["125905951"],"URL":"https:\/\/doi.org\/10.1016\/j.jegh.2013.11.003","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}